Therefore, understanding the mechanisms through which microbial-derived SCFAs influence CD8+ T cells opens new avenues for therapeutic interventions aimed at enhancing CD8+ T cell efficacy across a spectrum of cancer and viral infections. The gene discussed is CD8A; the disease is viral infectious disease.